Mangafodipir as an Adjunct to Percutaneous Coronary Intervention in Acute Myocardial Infarction (MANAMI)
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Mangafodipir (Primary)
- Indications Myocardial infarction
- Focus Biomarker; Therapeutic Use
- Acronyms MANAMI
- Sponsors PledPharma
- 14 Oct 2013 Full results will be presented at a future scientific meeting.
- 14 Oct 2013 Results published in the Media Release.
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History